Celsius Therapeutics

Celsius turns up the heat with lead drug selection, $83M funding

The temperature is rising at Celsius as the precision-medicine-focused biotech picks a lead candidate and reels in $83 million in funding.

Sophia Sorensen Mar 24, 2022 8:00am

What does a virtual J.P. Morgan mean for the meeting's future?

Jan 12, 2021 11:00am

This year's Fierce 15 winners on IPO trends and the decade ahead

Oct 29, 2019 11:27am